ICODE: the international COVID-19 thrombosis biomarkers colloquium-novel soluble biomarkers: circulating cell-free nucleic acids and other molecules.

Abstract

This article summarizes the evidence derived from clinical (observational) studies describing novel soluble biomarkers in COVID-19. Our goal was to stimulate further research (preclinical as well as clinical studies) and therefore we discuss potential prognostic value, but also technical details, such as sample preparation. A table provides an overview of the described biomarkers measured in plasma, serum or other (namely bronchoalveolar) fluids.

• Authors: Krystin Krauel, Daniel Duerschmied
• Journal: Journal of thrombosis and thrombolysis (J Thromb Thrombolysis) Vol. 53 Issue 1 Pg. 83-87 (Jan 2022) ISSN: 1573-742X [Electronic] Netherlands
• PMID: 33982161 (Publication Type: Journal Article)
• Copyright: © 2021. The Author(s).

Chemical References

• Biomarkers
• Cell-Free Nucleic Acids

Topics

• Biomarkers (blood)
• COVID-19 (diagnosis)
• Cell-Free Nucleic Acids (blood)
• Humans
• Observational Studies as Topic
• Thrombosis (diagnosis)